» Articles » PMID: 30543658

Next-generation Sequencing Identifies Unexpected Genotype-phenotype Correlations in Patients with Retinitis Pigmentosa

Overview
Journal PLoS One
Date 2018 Dec 14
PMID 30543658
Citations 46
Authors
Affiliations
Soon will be listed here.
Abstract

Retinitis pigmentosa (RP) is an inherited degenerative disease causing severe retinal dystrophy and visual impairment mainly with onset in infancy or adolescence. Targeted next-generation sequencing (NGS) has become an efficient tool to encounter the enormous genetic heterogeneity of diverse retinal dystrophies, including RP. To identify disease-causing mutations in unselected, consecutive RP patients, we conducted Sanger sequencing of genes commonly involved in the suspected genetic RP subtype, followed by targeted large-panel NGS if no mutation was identified, or NGS as primary analysis. A high (70%) detection rate of disease-causing mutations was achieved in a large cohort of 116 unrelated patients. About half (48%) of the solved RP cases were explained by mutations in four genes: RPGR, EYS, PRPF31 and USH2A. Overall, 110 different mutations distributed across 30 different genes were detected, and 46 of these mutations were novel. A molecular diagnosis was achieved in the majority (82-100%) of patients if the family history was suggestive for a particular mode of inheritance, but only in 60% in cases of sporadic RP. The diagnostic potential of extensive molecular analysis in a routine setting is also illustrated by the identification of unexpected genotype-phenotype correlations for RP patients with mutations in CRX, CEP290, RPGRIP1, MFSD8. Furthermore, we identified numerous mutations in autosomal dominant (PRPF31, PRPH2, CRX) and X-linked (RPGR) RP genes in patients with sporadic RP. Variants in RP2 and RPGR were also found in female RP patients with apparently sporadic or dominant disease. In summary, this study demonstrates that massively parallel sequencing of all known retinal dystrophy genes is a valuable diagnostic approach for RP patients.

Citing Articles

Ciliopathy-associated protein, CEP290, is required for ciliary necklace and outer segment membrane formation in retinal photoreceptors.

Moye A, Robichaux M, Agosto M, Rivolta C, Moulin A, Wensel T bioRxiv. 2025; .

PMID: 39896654 PMC: 11785020. DOI: 10.1101/2025.01.20.633784.


Neuronal ceroid lipofuscinoses type 7 (CLN7): a case series reporting cross sectional and retrospective clinical data to evaluate validity of standardized tools to assess disease progression, quality of life, and adaptive skills.

Kayani S, BordesEdgar V, Lowden A, Nettesheim E, Dahshi H, Messahel S Orphanet J Rare Dis. 2024; 19(1):468.

PMID: 39702211 PMC: 11657365. DOI: 10.1186/s13023-024-03448-8.


A novel compound heterozygous PCDH15 variants is associated with arRP in a Chinese pedigree.

Yang H, Zhang Y, Zhu L, Zheng W, Shi M, Zhao W BMC Ophthalmol. 2024; 24(1):373.

PMID: 39187782 PMC: 11345949. DOI: 10.1186/s12886-024-03640-1.


Maculopathy and adult-onset ataxia in patients with biallelic MFSD8 variants.

Dobloug S, Kjellstrom U, Anderson G, Gardner E, Mole S, Sheth J Mol Genet Genomic Med. 2024; 12(8):e2505.

PMID: 39108195 PMC: 11303817. DOI: 10.1002/mgg3.2505.


Neuronal Ceroid Lipofuscinoses Type 7 (CLN7)- A Case Series Reporting Cross Sectional and Retrospective Clinical Data to Evaluate Validity of Standardized Tools to Assess Disease Progression, Quality of Life, and Adaptive Skills.

Kayani S, Bordes Edgar V, Lowden A, Nettesheim E, Dahshi H, Messahel S Res Sq. 2024; .

PMID: 38978590 PMC: 11230482. DOI: 10.21203/rs.3.rs-3983366/v1.


References
1.
Oishi M, Oishi A, Gotoh N, Ogino K, Higasa K, Iida K . Comprehensive molecular diagnosis of a large cohort of Japanese retinitis pigmentosa and Usher syndrome patients by next-generation sequencing. Invest Ophthalmol Vis Sci. 2014; 55(11):7369-75. DOI: 10.1167/iovs.14-15458. View

2.
Pomares E, Riera M, Castro-Navarro J, Andres-Gutierrez A, Gonzalez-Duarte R, Marfany G . Identification of an intronic single-point mutation in RP2 as the cause of semidominant X-linked retinitis pigmentosa. Invest Ophthalmol Vis Sci. 2009; 50(11):5107-14. DOI: 10.1167/iovs.08-3208. View

3.
Hamel C . Retinitis pigmentosa. Orphanet J Rare Dis. 2006; 1:40. PMC: 1621055. DOI: 10.1186/1750-1172-1-40. View

4.
Neveling K, Collin R, Gilissen C, van Huet R, Visser L, Kwint M . Next-generation genetic testing for retinitis pigmentosa. Hum Mutat. 2012; 33(6):963-72. PMC: 3490376. DOI: 10.1002/humu.22045. View

5.
Comander J, Weigel-DiFranco C, Sandberg M, Berson E . Visual Function in Carriers of X-Linked Retinitis Pigmentosa. Ophthalmology. 2015; 122(9):1899-906. PMC: 4562908. DOI: 10.1016/j.ophtha.2015.05.039. View